Category
Bortezomib
CAS Number
1446194-56-4
Molecular Formula
C19H24N4O2
Molecular Weight
340.4 g/mol
Synonym

N-[(2S)-1-(3-methylbutylamino)-1-oxo-3-phenylpropan-2-yl]pyrazine-2-carboxamide; (S)-N-(1-(Isopentylamino)-1-oxo-3-phenylpropan-2-yl)pyrazine-2-carboxamide; N-[(1S)-2-[(3-Methylbutyl)amino]-2-oxo-1-(phenylmethyl)ethyl]-2-pyrazinecarboxamide

Keywords
Chiral standards
boron derivatives
Enzyme inhibitors
Pharmaceutical Standards
Intermediates
Fine Chemicals
slide.1
Purity:

Above - 95.0%

Technical Data:

We will provide complete documentation support for every Standard Material. All analytical reports such as ¹H NMR, ¹³C NMR, Mass, FT-IR, HPLC Purity/GC Purity/QNMR Purity, Water content by KF/ Loss on Drying/TGA (Thermo-gravimetric Analysis). Certificate of Analysis with potency report. Each Standard Material SER (Structure Elucidation Report) with NMR, Mass, IR spectral interpretation. This whole analytical document can be included in eCTD, ANDA, DMF submissions to regulatory agencies.

Bortezomib Impurity H is a specific impurity of Bortezomib that can occur during synthesis, formulation, or storage. This impurity has a chemical structure slightly different from the active drug, and its presence is carefully monitored to ensure it does not compromise the drug’s potency, safety, or overall stability.